| Typicality: | 0.547 |
| Saliency: | 0.431 |
| in the united states | 4 | location |
| to humans | 4 | transitive-object |
| for use in children | 3 | purpose |
| drug → be → experimental | 63 |
| drug → be considered → experimental | 13 |
| negative | neutral | positive |
| 0.323 | 0.565 | 0.112 |
| Raw frequency | 76 |
| Normalized frequency | 0.431 |
| Modifier score | 0.850 |
| Perplexity | 336.486 |